| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 10.27M | — |
| Operating expense | — | — |
| Net income | -21.97M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, JANX returned -28.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +26.0% |
| 1 year | -28.4% |
| 5 years | -49.0% |
| All-time high | $57.00 (Apr 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in JANX would be worth today ›No. Janux Therapeutics, Inc. has not paid a dividend in the past 12 months.
Janux Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol JANX.
Janux Therapeutics, Inc. is part of the Healthcare sector.
Janux Therapeutics, Inc. has a market cap of 1.06B USD, based on the latest quote.
Janux Therapeutics, Inc. is expected to report earnings around Nov 5, 2026. That date is an estimate and has not been confirmed by the company.
